BiotechTubeBiotechTube
Home/Day One Biopharmaceuticals/Davy Chiodin
DC

Davy Chiodin

Chief Development Officer

Day One Biopharmaceuticals

Therapeutic Areas

OncologyPediatric OncologyNeuro-Oncology

Day One Biopharmaceuticals Pipeline

DrugIndicationPhase
OJEMDA™ (tovorafenib)Pediatric low-grade glioma (pLGG) with BRAF alterationsApproved
Emi-LeUndisclosed solid tumors (Novel ADC)Phase 1

Leadership Team at Day One Biopharmaceuticals

JB
Jeremy Bender
Chief Executive Officer, President
EB
Elly Barry
Chief Medical Officer
MV
Michael Vasconelles
Head of R&D
DL
David Lee
Senior Director, Market Planning
View full Day One Biopharmaceuticals profile